Stock Events

Biosenic 

€0.03
10
-€0-6.25% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
3.28M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

6MarExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
-0.15
-0.1
-0.05
0
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BIOS.BR. It's not an investment recommendation.

About

As of October 25, 2022, Bone Therapeutics SA was acquired by Medsenic SAS, in a reverse merger transaction. Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.
Show more...
CEO
Dr. Miguel Forte M.D., Ph.D.
Employees
20
Country
BE
ISIN
BE0974280126
WKN
000A14NHV

Listings